Dennis A. Eichenauer

Author

Also Known As

D A Eichenauer, D Eichenauer, D. A. Eichenauer, D. Eichenauer, D.A. Eichenauer, DA Eichenauer, Dennis A. Eichenauer, Dennis A Eichenauer, Dennis A. Eichenauer, Dennis Alexander Eichenauer

234

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

University Hospital Cologne University of Cologne University of Duisburg-Essen Goethe University Frankfurt Charité - Universitätsmedizin Berlin

About

Dennis A. Eichenauer is an author at University Hospital Cologne specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	18	1.6K
2	Health Sciences	4	4	571
3	Public Health	2	2	163
4	Biochemistry	1	1	29
5	Cell Biology	1	1	29

Dennis A. Eichenauer

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
COVID‐19 associated pulmonary aspergillosis Philipp Koehler, Oliver A. Cornely, Bernd W. Böttiger, Mycoses	2020	534
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Dennis A. Eichenauer, Andreas Engert, M. André, Annals of Oncology Lymphoid NeoplasiaSurgical OncologyMedicinePathologyLymphatic Disease	2014	476
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Dennis A. Eichenauer, Berthe M.P. Aleman, M. André, Annals of Oncology	2018	411
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group Peter Borchmann, Helen Goergen, Carsten Kobe, The Lancet Positron Emission TomographyAdvanced-stage HodgkinLymphoid NeoplasiaSurgical OncologyOncologic Imaging	2017	372
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma Achim Rothe, Stephanie Sasse, Max S. Topp, Blood	2015	320
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial François-Xavier Lescure, Hitoshi Honda, Robert Fowler, The Lancet Respiratory Medicine	2021	246
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG) Sylvia Hartmann, Dennis A. Eichenauer, Annette Plütschow, Blood	2013	188
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19 Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	147
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Blood	2014	136
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	133

Page 1